|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,431,828,055 |
|
|
Indirect Value
|
$7,287,641,839 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,719,469,894 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-08-20 |
4 |
D |
$3.00 |
$16,523,022 |
I/I |
(5,507,674) |
0 |
0 |
- |
|
NTII |
Neurobiological Technolog... |
Direct Beneficial Owner |
|
2009-10-21 |
4 |
S |
$0.91 |
$4,191,819 |
D/D |
(4,606,395) |
331,998 |
0 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
officerTitle |
|
2005-01-13 |
4 |
S |
$15.40 |
$670,978 |
I/I |
(43,570) |
985,163 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-07-08 |
4 |
S |
$5.00 |
$334,000 |
I/I |
(66,800) |
994,851 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-07-07 |
4 |
S |
$5.10 |
$3,885,176 |
I/I |
(761,288) |
1,026,851 |
|
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
officerTitle |
|
2006-01-13 |
4 |
S |
$15.40 |
$1,350,580 |
I/I |
(87,700) |
1,028,733 |
|
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
officerTitle |
|
2006-01-12 |
4 |
S |
$15.69 |
$2,491,704 |
I/I |
(158,700) |
1,116,433 |
|
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2005-08-11 |
4 |
S |
$11.92 |
$2,553,639 |
I/I |
(213,800) |
1,224,533 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-07-01 |
4 |
S |
$5.42 |
$514,900 |
I/I |
(95,000) |
1,395,351 |
|
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-07-25 |
4 |
B |
$8.99 |
$215,760 |
I/I |
24,000 |
1,416,733 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-08-13 |
4 |
B |
$8.78 |
$189,585 |
I/I |
21,600 |
1,438,333 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-06-29 |
4 |
S |
$5.31 |
$376,797 |
I/I |
(71,000) |
1,441,351 |
|
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
Indirect Beneficial Owner |
|
2003-10-27 |
4 |
S |
$8.00 |
$5,968,000 |
I/I |
(746,000) |
1,455,900 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-06-28 |
4 |
S |
$5.30 |
$287,010 |
I/I |
(54,000) |
1,476,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-06-18 |
4 |
S |
$5.52 |
$33,114 |
I/I |
(6,000) |
1,502,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-21 |
4 |
S |
$6.00 |
$297,000 |
I/I |
(49,500) |
1,556,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-20 |
4 |
S |
$6.00 |
$570,000 |
I/I |
(95,000) |
1,580,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-14 |
4 |
S |
$6.05 |
$574,750 |
I/I |
(95,000) |
1,626,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-09 |
4 |
S |
$6.30 |
$151,200 |
I/I |
(24,000) |
1,672,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-12-31 |
4 |
S |
$6.20 |
$7,359,400 |
I/I |
(1,187,000) |
1,684,351 |
|
- |
|
GYRE |
Gyre Therapeutics |
Indirect Beneficial Owner |
|
2009-10-16 |
4 |
S |
$23.60 |
$15,063,112 |
D/D |
(638,400) |
2,061,925 |
0 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2003-10-17 |
4 |
S |
$7.69 |
$22,385,590 |
I/I |
(2,911,000) |
2,259,351 |
|
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2003-07-17 |
4 |
B |
$3.90 |
$2,340 |
I/I |
600 |
2,424,023 |
1.42 |
- |
|
GYRE |
Gyre Therapeutics |
Direct Beneficial Owner |
|
2009-07-09 |
4 |
B |
$3.10 |
$66,646 |
D/D |
21,500 |
2,686,609 |
2.45 |
- |
|
GYRE |
Gyre Therapeutics |
Direct Beneficial Owner |
|
2009-07-10 |
4 |
B |
$2.79 |
$5,578 |
D/D |
2,000 |
2,688,609 |
2.37 |
- |
|
195 Records found
|
|
Page 1 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|